These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32701250)

  • 21. SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p.
    Bao J; Zhang S; Meng Q; Qin T
    Neurochem Res; 2020 Apr; 45(4):825-836. PubMed ID: 31919621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
    Chang N; Ge N; Zhao Y; Yang L; Qin W; Cui Y
    J Clin Lab Anal; 2022 May; 36(5):e24304. PubMed ID: 35312115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexmedetomidine inhibits the growth and metastasis of esophageal cancer cells by down-regulation of lncRNA MALAT1.
    Zhang W; Zhang L; Cai XJ; Li D; Cao FJ; Zuo ZG; Song Y; Yu XJ; Liu S
    Kaohsiung J Med Sci; 2022 Jun; 38(6):585-593. PubMed ID: 35199933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexmedetomidine represses proliferation and promotes apoptosis of esophageal cancer cells by regulating C-Myc gene expression via the ERK signaling pathway.
    Hu Y; Qiu LL; Zhao ZF; Long YX; Yang T
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):950-956. PubMed ID: 33577050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA H19 promotes the proliferation, migration and invasion while inhibits apoptosis of hypertrophic scarring fibroblasts by targeting miR-3187-3p/GAB1 axis.
    Xiao M; Zou X; Li B; Zhang B
    Burns; 2021 May; 47(3):654-664. PubMed ID: 32888745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dexmedetomidine suppresses hippocampal astrocyte pyroptosis in cerebral hypoxic-ischemic neonatal rats by upregulating microRNA-148a-3p to inactivate the STAT/JMJD3 axis.
    Zhong Y; Wang S; Yin Y; Yu J; Liu Y; Gao H
    Int Immunopharmacol; 2023 Aug; 121():110440. PubMed ID: 37327511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
    Tang Y; Yang P; Zhu Y; Su Y
    Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
    Wu K; Yang Y; Zhao J; Zhao S
    Cancer Lett; 2016 Feb; 371(1):125-33. PubMed ID: 26655271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.
    Ma J; Hong L; Xu G; Hao J; Wang R; Guo H; Liu J; Zhang Y; Nie Y; Fan D
    Cell Biol Int; 2016 Apr; 40(4):448-55. PubMed ID: 26801660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.
    Li Z; Yao H; Wang S; Li G; Gu X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway.
    Xi M; Cheng L; Hua W; Zhou YL; Gao QL; Yang JX; Qi SY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1002-1011. PubMed ID: 30779066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
    Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
    Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propofol disrupts cell carcinogenesis and aerobic glycolysis by regulating circTADA2A/miR-455-3p/FOXM1 axis in lung cancer.
    Zhao H; Wei H; He J; Wang D; Li W; Wang Y; Ai Y; Yang J
    Cell Cycle; 2020 Oct; 19(19):2538-2552. PubMed ID: 32857667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
    Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
    Liu X; Xie S; Zhang J; Kang Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528
    [No Abstract]   [Full Text] [Related]  

  • 38. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
    Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.